Evaluation of dual priming oligonucleotide-based multiplex PCR for detection of HBV YMDD mutants
暂无分享,去创建一个
Y. Kim | W. Jeon | H. Woo | B. Kim | Woongryul Jeon | H. Woo | H. Park | Y. Kim | Hyunkyung Park | Byung-Oh Kim
[1] Young-Jo Lee,et al. Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers. , 2008, Journal of virological methods.
[2] Qingge Li,et al. Real-time PCR detection of multiple lamivudine-resistant mutations with displacing probes in a single tube. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[3] I. Hwang,et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene , 2007, Nucleic acids research.
[4] Y. Cho,et al. Comparison of Mass Spectrometric Analysis and TRUGENE™ HBV Genotyping for Monitoring Lamivudine Resistance in Chronic Hepatitis B Patients , 2007, Antiviral therapy.
[5] J. Yeon,et al. Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough. , 2006, Gastroenterology.
[6] P. Lampertico,et al. Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine , 2005, Hepatology.
[7] S. Ahn,et al. Evaluation of Methods for Monitoring Drug Resistance in Chronic Hepatitis B Patients during Lamivudine Therapy Based on Mass Spectrometry and Reverse Hybridization , 2005, Antiviral therapy.
[8] 大石 和佳. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping , 2004 .
[9] A. Roque-Afonso,et al. Monitoring the Emergence of Hepatitis B Virus Polymerase Gene Variants during Lamivudine Therapy in Human Immunodeficiency Virus Coinfected Patients: Performance of Clip™ Sequencing and Line Probe Assay , 2002, Antiviral therapy.
[10] A. Wald,et al. Quantitative Stability of DNA after Extended Storage of Clinical Specimens as Determined by Real-Time PCR , 2002, Journal of Clinical Microbiology.
[11] D. Richman,et al. Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region , 2001, Hepatology.
[12] J. Villeneuve,et al. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance. , 2000, Journal of hepatology.
[13] M. Buti,et al. Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. , 1999, Journal of virological methods.
[14] F. Baldanti,et al. Two Sensitive PCR-Based Methods for Detection of Hepatitis B Virus Variants Associated with Reduced Susceptibility to Lamivudine , 1999, Journal of Clinical Microbiology.
[15] C. Chu,et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy , 1999, Hepatology.
[16] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .
[17] L. Comanor,et al. Assessment of Hepatitis B Virus DNA Stability in Serum by the Chiron Quantiplex Branched-DNA Assay , 1998, Journal of Clinical Microbiology.
[18] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. , 1998, Hepatology.